Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Catherine A, Koss"'
Autor:
Jane Kabami, Elijah Kakande, Gabriel Chamie, Laura B. Balzer, Maya L. Petersen, Carol S. Camlin, Marilyn Nyabuti, Catherine A. Koss, Elizabeth A. Bukusi, Moses R. Kamya, Diane V. Havlir, James Ayieko
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss S1, Pp n/a-n/a (2023)
Abstract Introduction Person‐centred HIV prevention delivery models that offer structured choices in product, testing and visit location may increase coverage. However, data are lacking on the actual uptake of choices among persons at risk of HIV i
Externí odkaz:
https://doaj.org/article/b53be6d13b744c449c73c3aa7c892d80
Autor:
Florence Mwangwa, Monica Getahun, Harriet Itiakorit, Vivek Jain, James Ayieko, Lawrence Owino, Cecilia Akatukwasa, Irene Maeri, Catherine A. Koss, Gabriel Chamie, Tamara D. Clark, Jane Kabami, Mucunguzi Atukunda, Dalsone Kwarisiima, Norton Sang, Elizabeth A. Bukusi, Moses R. Kamya, Maya L. Petersen, Craig R. Cohen, Edwin D. Charlebois, Diane V. Havlir, Carol S. Camlin
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 20 (2021)
The Sustainable East Africa Research in Community Health (SEARCH), a universal test and treat (UTT) trial, implemented ‘Streamlined Care’—a multicomponent strategy including rapid linkage to care and antiretroviral therapy (ART) start, 3-monthl
Externí odkaz:
https://doaj.org/article/cfe503c4590f483da7fd18ef4c9d9b7b
Autor:
Catherine A Koss, Diane V Havlir, James Ayieko, Dalsone Kwarisiima, Jane Kabami, Gabriel Chamie, Mucunguzi Atukunda, Yusuf Mwinike, Florence Mwangwa, Asiphas Owaraganise, James Peng, Winter Olilo, Katherine Snyman, Benard Awuonda, Tamara D Clark, Douglas Black, Joshua Nugent, Lillian B Brown, Carina Marquez, Hideaki Okochi, Kevin Zhang, Carol S Camlin, Vivek Jain, Monica Gandhi, Craig R Cohen, Elizabeth A Bukusi, Edwin D Charlebois, Maya L Petersen, Moses R Kamya, Laura B Balzer
Publikováno v:
PLoS Medicine, Vol 18, Iss 2, p e1003492 (2021)
BackgroundOral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but data are limited on HIV incidence among PrEP users in generalized epidemic settings, particularly outside of selected risk groups. We performed a population-ba
Externí odkaz:
https://doaj.org/article/f196f34e51ac463fa3637a85ee1bb193
Autor:
Carol S. Camlin, Monica Getahun, Catherine A. Koss, Lawrence Owino, Cecilia Akatukwasa, Harriet Itiakorit, Anjeline Onyango, Robert Bakanoma, Fredrick Atwine, Irene Maeri, James Ayieko, Mucunguzi Atukunda, Asiphas Owaraganise, Florence Mwangwa, Norton Sang, Jane Kabami, Rachel L. Kaplan, Gabriel Chamie, Maya L. Petersen, Craig R. Cohen, Elizabeth A. Bukusi, Moses R. Kamya, Diane V. Havlir, Edwin D. Charlebois
Publikováno v:
AIDS patient care and STDs. 36(10)
Pre-exposure prophylaxis (PrEP) implementation is underway across sub-Saharan Africa. However, little is known about health care providers' experiences with PrEP provision in generalized epidemic settings, particularly outside of selected risk groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824817039df2f6ffaa6c82452363471d
https://pubmed.ncbi.nlm.nih.gov/36201226
https://pubmed.ncbi.nlm.nih.gov/36201226
Autor:
Monica Gandhi, Peter Bacchetti, Warren C. Rodrigues, Matthew Spinelli, Catherine A. Koss, Paul K. Drain, Jared M. Baeten, Nelly R. Mugo, Kenneth Ngure, Leslie Z. Benet, Hideaki Okochi, Guohong Wang, Michael Vincent
Publikováno v:
EClinicalMedicine, Vol 2, Iss , Pp 22-28 (2018)
Background: Pharmacologic adherence measures were critical to the interpretation of the tenofovir (TFV)-disoproxil-fumarate/emtricitabine (TDF/FTC) PrEP trials. These measures are being incorporated into PrEP demonstration projects, but currently-ava
Externí odkaz:
https://doaj.org/article/bf8ce0e7374745d894c34567e5444ee8
Publikováno v:
Current HIV/AIDS Reports. 19:384-393
Purpose of Review Cabotegravir is a potent integrase strand transfer inhibitor (INSTI) recently approved as a long-acting injectable formulation for HIV prevention (CAB-LA). We summarize what is known about cabotegravir pharmacokinetics, activity, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c0f9b0fb1d9c9335a74fc28aeb028d
https://doi.org/10.1007/s11904-022-00616-y
https://doi.org/10.1007/s11904-022-00616-y
Autor:
Roy Gerona, Anita Wen, Aaron T Chin, Catherine A Koss, Peter Bacchetti, John Metcalfe, Monica Gandhi
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155887 (2016)
BACKGROUND:Tuberculosis (TB) is the leading cause of death from an infectious pathogen worldwide and the most prevalent opportunistic infection in people living with HIV. Isoniazid preventive therapy (IPT) reduces the incidence of active TB and reduc
Externí odkaz:
https://doaj.org/article/d6d561ef95db48019905c2794276f8e8
Autor:
Jane Kabami, Mucunguzi Atukunda, Diane V. Havlir, Craig R. Cohen, Catherine A. Koss, Elizabeth A. Bukusi, Norton Sang, Edwin D. Charlebois, Irene Maeri, Tamara D. Clark, James Ayieko, Vivek Jain, Monica Getahun, Florence Mwangwa, Moses R. Kamya, Gabriel Chamie, Harriet Itiakorit, Dalsone Kwarisiima, Carol S. Camlin, Cecilia Akatukwasa, Lawrence Owino, Maya L. Petersen
Publikováno v:
Journal of the International Association of Providers of AIDS Care
Journal of the International Association of Providers of AIDS Care, Vol 20 (2021)
Journal of the International Association of Providers of AIDS Care, Vol 20 (2021)
The Sustainable East Africa Research in Community Health (SEARCH), a universal test and treat (UTT) trial, implemented ‘Streamlined Care’—a multicomponent strategy including rapid linkage to care and antiretroviral therapy (ART) start, 3-monthl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6159b31ab6e964be35af5da56da4fa39
https://pubmed.ncbi.nlm.nih.gov/34841945
https://pubmed.ncbi.nlm.nih.gov/34841945
Autor:
Catherine A Koss, Leah G Jarlsberg, Saskia den Boon, Adithya Cattamanchi, J Lucian Davis, William Worodria, Irene Ayakaka, Ingvar Sanyu, Laurence Huang, International HIV-associated Opportunistic Pneumonias (IHOP) Study
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126591 (2015)
BackgroundPneumonia is a major cause of mortality among HIV-infected patients. Pneumonia severity scores are promising tools to assist clinicians in predicting patients' 30-day mortality, but existing scores were developed in populations infected wit
Externí odkaz:
https://doaj.org/article/630f627aa8ea44c8ab3b17f92b82a644
Autor:
Moses R. Kamya, Dalsone Kwarisiima, Jane Kabami, Mucunguzi Atukunda, Gabriel Chamie, Norton Sang, Elizabeth A. Bukusi, Craig R. Cohen, Catherine A. Koss, Edwin D. Charlebois, Maya L. Petersen, Mark J. van der Laan, Diane V. Havlir, James Ayieko, Vivek Jain, Carol S. Camlin, Laura B. Balzer, Tamara D. Clark
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 71, iss 9
Clin Infect Dis
Clin Infect Dis
Background In generalized epidemic settings, strategies are needed to prioritize individuals at higher risk of human immunodeficiency virus (HIV) acquisition for prevention services. We used population-level HIV testing data from rural Kenya and Ugan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150dc5f18f4811a9c33bf0e199af3d80
https://doi.org/10.1093/cid/ciz1096
https://doi.org/10.1093/cid/ciz1096